PRS REIT (The)

Summary by AI ^BETAClose X

FTSE Russell has announced changes to the FTSE UK Index Series, effective from the open on Monday, December 22, 2025. Following the disposal of its entire property portfolio and reclassification, The PRS REIT (UK) will be deleted from the FTSE 250 Index. Applied Nutrition (UK) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index. All other details from previous notices remain unchanged.

Disclaimer*

FTSE Russell

17 December 2025

Further to the FTSE notice released on 15 December 2025 in relation to The PRS REIT (UK): Constituent Deletion, please note the FTSE 250 Index replacement and associated changes.

All other details remain unchanged. Please see updated notice below:

The PRS REIT (UK): Constituent Deletion - Update
Changes in FTSE UK Index Series

17 December 2025

Further to the FTSE Russell notice published on 09 December 2025 and following the disposal of the entire property portfolio held by The PRS REIT (UK, constituent), and subsequent reclassification to an ineligible ICB, please see details of affected indexes and effective dates below:

The PRS REIT (UK, BF01NH5) will be deleted from the FTSE 250 Index.

Applied Nutrition (UK, BPVDXX6) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

All changes effective from the open of Monday 22 December 2025.

Full details of changes are available on the FTSE Russell website.

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia	+61 (0) 2 7228 5659
Hong Kong	+852 2164 3333
Japan	+81 3 6441 1430
London	+44 (0) 20 7866 1810
New York	+1877 503 6437

Alternatively, please visit our website at lseg.com/ftse-russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END